Standard Chartered CEO Apologizes for Lower Value Human Capital Remark
SpaceX Initiates Investor Roadshow Following Latest Starship Launch
OpenAI Poised for Confidential IPO Filing Signaling Race to Public Markets
European AI Trade Dependency Risk Report Warns of Dependency Trap with US and Asia
Google Pixel Launch Google Assistants AI Capabilities Intensify Privacy Debate
China Urges APEC Cooperation as Commerce Minister Skips Opening Session
AES Q1 2026 Earnings Massive EPS Beat of 8025 Surprises Analysts
MLI Q1 2026 Earnings Strong Earnings Beat as EPS Surges Past Estimates
Envoy Medical Inc COCH Q1 2026 Earnings Strong EPS Beat Amidst PreRevenue Stage
Altimmune Inc ALT Q1 2026 Earnings EPS Beat Surprises to the Upside Amid Pipeline Progress
Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery
ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty
Roboai Inc AIIO Plunges 17 as Investor Sentiment Sours Approaches Key Support
Nu Holdings NU Sees 33 Decline as Shares Test Key Support Zone
Meiwu Technology WNW Shares Slide 76 as Support Levels Come into Focus
Simmons First National Shows Modest Gains as Stock Holds Above Key Support
Mannatech MTEX Surges 288 as Stock Tests Key Resistance Levels
Gold Prices Dip as Feds Waller Flags Potential Rate Hike Amid Iran Energy Shock
Union Pacific Corporation UNP Q1 2026 Earnings EPS Beat Amid Operational Efficiency Gains
NextNav Inc NN Gains 168 as Stock Tests Key Resistance Near 2283
CVEO Q1 2026 Earnings EPS Surprise of 45 Despite Negative Earnings
TaoWeave Inc TWAV Q3 2022 Earnings Significant EPS Miss Sends Stock Lower
MSBIP Q1 2026 Earnings Preferred Shares Deliver Strong EPS Beat Amid Steady Market Reception
UBS Q1 2026 Earnings EPS Surpasses Expectations Stock Rises 175
RMTI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Weak Performance
Dine Brands Q1 2026 Earnings EPS Beats Estimates by 53 Amid Operational Discipline
ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues